In line with these findings, the VLDL and LDL serum levels of Apolipoprotein E deficient mice (ApoE-/-), a dyslipidemia derived atherosclerosis model, expressing hypomorphic NEU1 were also diminished and atherogenic plaque size was tempered (>50%). Here, APOE is linked to metabolic syndrome.